Used in pharmaceutical research as a key intermediate in the synthesis of neuroactive compounds, particularly those targeting central nervous system disorders. Its structure supports the development of agents with potential antidepressant and cognitive-enhancing effects. The trifluoroethanone moiety enhances metabolic stability, making it valuable in optimizing drug candidates for improved bioavailability and longer half-life. Currently investigated for its role in modulating monoaminergic pathways, especially dopamine and serotonin receptors.